145P I-SAbR in unresectable LA-NSCLC patients receiving durvalumab in START-NEW-ERA non-randomised phase II trialP. Anselmo,F. Trippa,C. Zannori,M. Italiani,M. Casale,F. ArcidiaconoESMO Open(2024)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要